Patient P-03067

Synthetic patientONX-7 · Day 107 · 45–54 · F · baseline S06Steering view · 3D Open companion preview

Therapy response

Declining

Tolerance

Favorable

GI state

Improving

Inflammatory state

Favorable

Nutritional resilience

Favorable

Discontinuation risk

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events

solid = observed · dashed = predicted

Day 0 ONX-7 started — Baseline state S06
Day 13 Trajectory diverged from prediction — Observed response fell below the model's expected path.
Day 18 DT-01 recommended — Dosing / Timing Recommendation DT-01
Day 19 Patient accepted — Started DT-01 in the companion
Day 24 No meaningful change — Dosing / Timing Recommendation DT-01

What changed?

Trajectory began diverging from predicted response on Day 13.

Primary contributors, last 14 days

GI instability-11
Treatment adherence-3
Toxicity+2

What helped?

Dosing / Timing Recommendation DT-01Day 18
Result: no meaningful change

LIFE OS recommendation

No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

Energy level

Daily log

6.8/10

improving · +0.8 vs previous 14 d

Stress level

Daily log

3.8/10

improving · -0.8 vs previous 14 d

Pessimism score

Daily log

3.6/10

improving · -0.3 vs previous 14 d

Sleep quality

Wearable

53.1/100

improving · +5.7 vs previous 14 d

Libido

Daily log

4.8/10

improving · +0.5 vs previous 14 d

HRV

Wearable

68.7 ms

improving · +5.3 vs previous 14 d

Toxicity

Blood

14.1/100

improving · -4.9 vs previous 14 d

This trajectory is decaying — what would help, what would not

Steering view →

Heading towards failing · 75 from the failing basin, 29 from restoration.

Would help

No untried action with strong evidence. Compose one from primitives.
More protein
GI -5.3 next day on high-intake days · n 26

Would not help

DT-01 Dosing / Timing Recommendation
already tried, no meaningful change
AD-05 Adherence Support
only 27% improved among 15 similar
Keep fat low
GI +6 next day on high-intake days · n 16
Keep lactose low
GI +3.9 next day on high-intake days · n 12

State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

Dietary fat load
+6detractor · 95%
Protein
-5.3supporter · 95%
Lactose
+3.9detractor · 83%
Caffeine
-0.9no signal · 17%
Alcohol
+0.4no signal · 15%
Histamine load
-0.2no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure

Butyrate / short-chain fatty acid production ↓35
- MicrobiomeButyrate capacity 29/100
Drug metabolism and exposure ↑35
- DNADPYD *2A → slower clearance

DNA

Fictional pharmacogenomic panel

DPYD *2A heterozygous
Slower drug clearance
CYP2D6 Normal metabolizer
Expected exposure

Microbiome

Shannon diversity 2.1 · butyrate capacity 29/100

Akkermansia muciniphilaNormal
Faecalibacterium prausnitziiNormal
Bacteroides fragilisNormal
Bifidobacterium longumLow
EnterobacteriaceaeHigh

Wearable, last 14 days

daily evolution fed into the runtime

HRV: 72 ms
Sleep: 7.4 h
Steps: 4,904
Resting HR: 55 bpm

Daily log: GI score 14, nutritional resilience 63, adherence 93.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview

What to eat

Keep meals regular; three to four moderate portions spaced through the day
Include a cooked vegetable portion with each main meal
Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
Avoid known triggers for now: fried or oily food, dairy, alcohol

What to do

Log the daily check-in; one line is enough
Keep the current walking rhythm
Keep the sleep window steady
Keep hydration steady: small amounts through the day rather than large volumes at once

What to take

Take the scheduled dose as agreed with your care team
No additional supplements this week
Fictional demo item: continue vitamin D as before

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

Patient	Similarity	Baseline	Intervention	Outcome	Response today
P-03105	38%	S12	AD-05	no change	60
P-03204	37%	S16	AD-05	improved	48
P-03351	37%	S07	AD-05	no change	51
P-03369	35%	S18	AD-05	no change	37
P-03441	35%	S19	AD-05	improved	37
P-03034	33%	S14	AD-05	no change	30
P-03122	33%	S13	AD-05	no change	40
P-03380	32%	S16	AD-05	improved	34
P-03424	32%	S12	AD-05	improved	41
P-03111	31%	S07	AD-05	no change	48
P-03129	31%	S18	AD-05	no change	32
P-03158	30%	S17	AD-05	no change	37